Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma
Clinical trial NCT03456466 · UNKNOWN
Trial details
- NCT number
- NCT03456466
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2018-06-30
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.